MedTrace Logo

STAR*D Alcohol: Treatment of Depression Concurrent With Alcohol Abuse

NCT00369746 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 674

Last updated 2014-05-09

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine if having an alcohol use disorder affects recovery from depression, and also whether recovery from depression in patients who have alcohol use disorders is also accompanied by improvement in the alcohol use disorder.

Conditions

Interventions

DRUG

citalopram

tablets, 60 mg maximum, daily, 12 weeks

Sponsors & Collaborators

  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)

    collaborator NIH

  • New York State Psychiatric Institute

    lead OTHER

Principal Investigators

  • Patrick J. McGrath, MD · New York State Psychiatric Institute

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-09-30
Primary Completion
2009-02-28
Completion
2009-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00369746 on ClinicalTrials.gov